Skip to main content
OpenTrials
Completed

NCT Number: NCT02265367

Novel Medication as a Potential Smoking Cessation Aid

The purpose of this study is to provide preliminary information assessing if levomilnacipran may be effective at increasing smoking cessation rates.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Tobacco Use Disorder Chemically-Induced Disorders Mental Disorders Substance-Related Disorders

Age range

25 year–55 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Clinical and Translational Sciences Institute

Minneapolis, Minnesota, 55455, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Be between 25 years old and 55 years old
  • Smoke a minimum number of cigarettes per day
  • Indicate motivation to quit smoking

Exclusion criteria

  • Current or history of medical or psychiatric conditions that could interfere with measures being studied or that could be affected by the study medication
  • Use of medication that could interfere with measures to be studied or that could be expected to interact with levomilnacipran
  • Are pregnant or breast feeding

The investigators will evaluate if there are other reasons why someone may not be eligible to participate

Treatment and study plan

Levomilnacipran

Drug

Other names: Fetzima

Placebo

Drug

Primary outcomes

  1. Percent of Days of Confirmed Abstinence (Out of 5 Maximum)

    Time frame: 5 days

    Subjects will be asked to abstain for five consecutive days during the third week of each intervention period with the percentage of confirmed abstinence days being the primary outcome measure

Sponsors and collaborators

Lead sponsor

University of Minnesota

Other

Registry information

Important dates

Study start
2015
Primary completion
2017
Study completion
2017
First posted
Oct 15, 2014
Registry last updated
Apr 22, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.